Lonza Group Ltd (SWX:LONN) announces that Lonza has granted Genentech, Inc. (NYSE:DNA) a non-exclusive, worldwide license to their GS Gene Expression System. The research evaluation agreement covers use of the GS System for research and development purposes. The agreement includes options for a Multi Product License to the GS System for commercial purposes, and further options to obtain licenses for the use of Lonza’s proprietary Protein Free Media System for both research and development as well as commercial purposes. The Agreement includes license fees and milestone payments, the financial terms of which have not been disclosed.
